GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO ...

Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization ...

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today ...

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic(R) technology has been licensed by Ginkgo ...

Dutch privately-held company ProteoNic, a provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic technology has been ...

Researchers are using reaction networks and dynamical systems to study these hidden patterns in living systems: Reports ...

CH Revenue Management Solutions (CHRMS), a leading authority in revenue protection for independent and out-of-network surgeons, today announced the launch of a five-part educational series on the No ...

ARS, the nation's leading provider of air conditioning, heating, and plumbing services, is honoring community heroes across the country with its ARS Cares program. More than 45 families will be the ...

Based on initial positive results from HOPE-B, etranacogene dezaparvovec became the first gene therapy approved for adults ...

This important study reveals that mitotic release of an ER-microtubule tether is critical for normal mitotic progression. Manipulating CLIMP63 phosphorylation, the authors provide convincing evidence ...

ETX101 uses an adeno-associated viral (AAV) vector to deliver a transcription factor for the SCN1A gene, given by ...

Doctoral Landscape Programme provides up to 18 fully funded PhD studentships available for October 2026. This programme will train students in interdisciplinary approaches to infection biosciences ...